{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T02:38:37Z","timestamp":1761100717632},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2004,5,31]],"date-time":"2004-05-31T00:00:00Z","timestamp":1085961600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2004,5,31]],"date-time":"2004-05-31T00:00:00Z","timestamp":1085961600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2004,7,1]]},"DOI":"10.1038\/sj.bmt.1704551","type":"journal-article","created":{"date-parts":[[2004,5,31]],"date-time":"2004-05-31T09:09:21Z","timestamp":1085994561000},"page":"175-179","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["A model of in vivo purging with Rituximab and high-dose AraC in follicular and mantle cell lymphoma"],"prefix":"10.1038","volume":"34","author":[{"given":"L","family":"Arcaini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E","family":"Orlandi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E P","family":"Alessandrino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I","family":"Iacona","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E","family":"Brusamolino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Bonfichi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P","family":"Bernasconi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Calatroni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Tenore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F","family":"Montanari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D","family":"Troletti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C","family":"Pascutto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Regazzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Lazzarino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2004,5,31]]},"reference":[{"key":"BF1704551_CR1","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1182\/blood.V100.4.1141.h81602001141_1141_1152","volume":"100","author":"M Hunault-Berger","year":"2002","unstructured":"Hunault-Berger M, Ifrah N, Solal-Celigny P . Intensive therapies in follicular non-Hodgkin lymphomas. Blood 2002; 100: 1141\u20131152.","journal-title":"Blood"},{"key":"BF1704551_CR2","doi-asserted-by":"publisher","first-page":"2288","DOI":"10.1200\/JCO.1997.15.6.2288","volume":"15","author":"IG McQuaker","year":"1997","unstructured":"McQuaker IG, Haynes AP, Anderson S et al. Engraftment and molecular monitoring of CD34+ peripheral-blood stem-cell transplants for follicular lymphoma: a pilot study. J Clin Oncol 1997; 15: 2288\u20132295.","journal-title":"J Clin Oncol"},{"key":"BF1704551_CR3","doi-asserted-by":"crossref","first-page":"3275","DOI":"10.1182\/blood.V78.12.3275.3275","volume":"78","author":"JG Gribben","year":"1991","unstructured":"Gribben JG, Freedman AS, Woo SD et al. All advanced stage non-Hodgkin's lymphomas with a polymerase chain reaction amplifiable breakpoint of bcl-2 have residual cells containing the bcl-2 rearrangement at evaluation and after treatment. Blood 1991; 78: 3275\u20133280.","journal-title":"Blood"},{"key":"BF1704551_CR4","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1200\/JCO.1996.14.1.214","volume":"14","author":"JG Sharp","year":"1996","unstructured":"Sharp JG, Kessinger A, Mann S et al. Outcome of high-dose therapy and autologous transplantation in non-Hodgkin's lymphoma based on the presence of tumor in the marrow or infused hematopoietic harvest. J Clin Oncol 1996; 14: 214\u2013219.","journal-title":"J Clin Oncol"},{"key":"BF1704551_CR5","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1182\/blood.V91.1.331","volume":"91","author":"BM Leonard","year":"1998","unstructured":"Leonard BM, Hetu F, Busque L et al. Lymphoma cell burden in progenitor cell grafts measured by competitive polymerase chain reaction: less than one log difference between bone marrow and peripheral blood sources. Blood 1998; 91: 331\u2013339.","journal-title":"Blood"},{"key":"BF1704551_CR6","doi-asserted-by":"crossref","first-page":"3449","DOI":"10.1182\/blood.V81.12.3449.3449","volume":"8","author":"JG Gribben","year":"1993","unstructured":"Gribben JG, Neuberg D, Freedman AS et al. Detection by polymerase chain reaction of residual cells with the bcl-2 translocation is associated with increased risk of relapse after autologous bone marrow transplantation for B-cell lymphoma. Blood 1993; 8: 3449\u20133457.","journal-title":"Blood"},{"key":"BF1704551_CR7","doi-asserted-by":"crossref","first-page":"3325","DOI":"10.1182\/blood.V94.10.3325.422k13_3325_3333","volume":"94","author":"AS Freedman","year":"1999","unstructured":"Freedman AS, Neuberg D, Mauch P et al. Long-term follow-up of autologous bone marrow transplantation in patients with relapsed follicular lymphomas. Blood 1999; 94: 3325\u20133333.","journal-title":"Blood"},{"key":"BF1704551_CR8","doi-asserted-by":"publisher","first-page":"2803","DOI":"10.1200\/JCO.1998.16.8.2803","volume":"16","author":"L Fouillard","year":"1998","unstructured":"Fouillard L, Laporte JP, Labopin M et al. Autologous stem-cell transplantation for non-Hodgkin's lymphomas: the role of graft purging and radiotherapy posttransplantation\u2014results of a retrospective analysis on 120 patients autografted in a single institution. J Clin Oncol 1998; 16: 2803\u20132816.","journal-title":"J Clin Oncol"},{"key":"BF1704551_CR9","doi-asserted-by":"publisher","first-page":"313","DOI":"10.3109\/10428199609054834","volume":"23","author":"V Yerly-Motta","year":"1996","unstructured":"Yerly-Motta V, Racadot E, Fest T et al. Comparative preclinical study of three bone marrow purging methods using PCR evaluation of residual t(14;18) lymphoma cells. Leukemia Lymphoma 1996; 23: 313\u2013321.","journal-title":"Leukemia Lymphoma"},{"key":"BF1704551_CR10","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1038\/sj.bmt.1701612","volume":"23","author":"GA Martin-Henao","year":"1999","unstructured":"Martin-Henao GA, Picon M, Limon A et al. Immunomagnetic bone marrow (BM) and peripheral blood progenitor cell (PBPC) purging in follicular lymphoma (FL). Bone Marrow Transplant 1999; 23: 579\u2013587.","journal-title":"Bone Marrow Transplant"},{"key":"BF1704551_CR11","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1002\/stem.150297","volume":"15","author":"U Paulus","year":"1997","unstructured":"Paulus U, Dreger P, Viehmann K et al. Purging peripheral blood progenitor cell grafts from lymphoma cells: quantitative comparison of immunomagnetic CD34+ selection systems. Stem Cells 1997; 15: 297\u2013304.","journal-title":"Stem Cells"},{"key":"BF1704551_CR12","doi-asserted-by":"publisher","first-page":"2825","DOI":"10.1200\/JCO.1998.16.8.2825","volume":"16","author":"P McLaughlin","year":"1998","unstructured":"McLaughlin P, Grillo-Lopez AJ, Link BK et al. Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma. Half of patients respond to a four-dose treatment program. J Clin Oncol 1998; 16: 2825\u20132833.","journal-title":"J Clin Oncol"},{"key":"BF1704551_CR13","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1089\/cbr.1997.12.177","volume":"12","author":"A Demidem","year":"1997","unstructured":"Demidem A, Lam T, Alas S et al. Chimeric anti-CD20 (IDEC-C2B8) monoclonal antibody sensitizes a B cell lymphoma cell line to cell killing by cytotoxic drugs. Cancer Biother Radiopharm 1997; 12: 177\u2013186.","journal-title":"Cancer Biother Radiopharm"},{"key":"BF1704551_CR14","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1200\/JCO.1999.17.1.268","volume":"17","author":"MS Czuczman","year":"1999","unstructured":"Czuczman MS, Grillo-L\u00f3pez AJ, White CA et al. Treatment of patients with low-grade B-cell lymphoma with the combination of chimeric anti-CD20 monoclonal antibody and CHOP chemotherapy. J Clin Oncol 1999; 17: 268\u2013276.","journal-title":"J Clin Oncol"},{"issue":"Suppl. 14","key":"BF1704551_CR15","first-page":"115","volume":"26","author":"R Buckstein","year":"1999","unstructured":"Buckstein R, Imrie K, Spaner D et al. Stem cell function and engraftment is not affected by \u2018in vivo purging\u2019 with rituximab for autologous stem cell treatment for patients with low-grade non-Hodgkin's lymphoma. Semin Oncol 1999; 26 (Suppl. 14): 115\u2013122.","journal-title":"Semin Oncol"},{"key":"BF1704551_CR16","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1016\/S1083-8791(00)70028-0","volume":"6","author":"IW Flinn","year":"2000","unstructured":"Flinn IW, O'Donnell PV, Goodrich A et al. Immunotherapy with rituximab during peripheral blood stem cell transplantation for non-Hodgkin's lymphoma. Biol Blood Marrow Transplant 2000; 6: 628\u2013632.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BF1704551_CR17","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1046\/j.1365-2141.2000.02084.x","volume":"109","author":"MT Voso","year":"2000","unstructured":"Voso MT, Pantel G, Weis M et al. In vivo depletion of B cells using a combination of high-dose cytosine arabinoside\/mitoxantrone and Rituximab for autografting in patients with non-Hodgkin's lymphoma. Br J Haematol 2000; 109: 729\u2013735.","journal-title":"Br J Haematol"},{"key":"BF1704551_CR18","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1182\/blood.V96.3.864","volume":"96","author":"M Magni","year":"2000","unstructured":"Magni M, Di Nicola M, Devizzi L et al. Successful in vivo purging of CD34-containing peripheral blood harvests in mantle cell and indolent lymphoma: evidence for a role of both chemotherapy and Rituximab infusion. Blood 2000; 96: 864\u2013869.","journal-title":"Blood"},{"key":"BF1704551_CR19","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1046\/j.1365-2141.2002.03256.x","volume":"116","author":"M Lazzarino","year":"2002","unstructured":"Lazzarino M, Arcaini L, Bernasconi P et al. A sequence of immuno-chemotherapy with Rituximab, mobilization of in vivo purged stem cells, high-dose chemotherapy and autotransplant is an effective and non-toxic treatment for advanced follicular and mantle cell lymphoma. Br J Haematol 2002; 116: 229\u2013235.","journal-title":"Br J Haematol"},{"key":"BF1704551_CR20","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1097\/00007691-200006000-00010","volume":"22","author":"I Iacona","year":"2000","unstructured":"Iacona I, Lazzarino M, Avanzini MA et al. Rituximab (IDEC-C2B8): validation of a sensitive enzyme-linked immunoassay applied to a clinical pharmacokinetic study. Ther Drug Monit 2000; 22: 295\u2013301.","journal-title":"Ther Drug Monit"},{"key":"BF1704551_CR21","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1182\/blood.V90.6.2188","volume":"90","author":"DG Maloney","year":"1997","unstructured":"Maloney DG, Grillo-Lopez AJ, White CA et al. IDEC-C2B8 (rituximab) anti-CD20 monoclonal antibody therapy in patients with relapsed low-grade non-Hodgkin's lymphoma. Blood 1997; 90: 2188\u20132195.","journal-title":"Blood"},{"key":"BF1704551_CR22","first-page":"1927","volume":"92","author":"B Coiffier","year":"1998","unstructured":"Coiffier B, Haioun C, Ketterer N et al. Rituximab (anti-CD20 monoclonal antibody) for the treatment of patients with relapsing or refractory aggressive lymphoma: a multicenter phase II study. Blood 1998; 92: 1927\u20131932.","journal-title":"Blood"},{"key":"BF1704551_CR23","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1200\/JCO.2001.19.2.389","volume":"19","author":"JM Vose","year":"2001","unstructured":"Vose JM, Link BK, Grossbard ML et al. Phase II study of rituximab in combination with CHOP chemotherapy in patients with previously untreated, aggressive non-Hodgkin's lymphoma. J Clin Oncol 2001; 19: 389\u2013397.","journal-title":"J Clin Oncol"},{"key":"BF1704551_CR24","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1056\/NEJMoa011795","volume":"346","author":"B Coiffier","year":"2002","unstructured":"Coiffier B, Lepage E, Briere J et al. CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma. N Engl J Med 2002; 346: 235\u2013242.","journal-title":"N Engl J Med"},{"key":"BF1704551_CR25","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1023\/A:1008389119525","volume":"10","author":"LD Piro","year":"1999","unstructured":"Piro LD, White CA, Grillo-Lopez AJ et al. Extended Rituximab (anti-CD20 monoclonal antibody) therapy for relapsed or refractory low-grade or follicular non-Hodgkin's lymphoma. Ann Oncol 1999; 10: 655\u2013661.","journal-title":"Ann Oncol"},{"issue":"Suppl. 1","key":"BF1704551_CR26","first-page":"141a","volume":"94","author":"G Salles","year":"1999","unstructured":"Salles G, Moullet I, Charlot C et al. In vivo purging with rituximab before autologous peripheral blood progenitor cell (PBPC) transplantation in lymphoma patients (pts). Blood 1999; 94 (Suppl. 1): 141a.","journal-title":"Blood"},{"key":"BF1704551_CR27","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1093\/annonc\/mdh090","volume":"15","author":"K Belhadj","year":"2004","unstructured":"Belhadj K, Delfau-Larue MH, Elgnaoui T et al. Efficiency of in vivo purging with Rituximab prior to autologous peripheral blood progenitor cell transplantation in B-cell non-Hodgkin's lymphoma: a single institution study. Ann Oncol 2004; 15: 504\u2013510.","journal-title":"Ann Oncol"},{"key":"BF1704551_CR28","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1038\/sj.leu.2401737","volume":"14","author":"C Tarella","year":"2000","unstructured":"Tarella C, Caracciolo D, Corradini P et al. Long-term follow-up of advanced-stage low-grade lymphoma patients treated upfront with high-dose sequential chemotherapy and autograft. Leukemia 2000; 14: 740\u2013747.","journal-title":"Leukemia"},{"key":"BF1704551_CR29","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1046\/j.0007-1048.2001.03313.x","volume":"116","author":"C Straka","year":"2002","unstructured":"Straka C, Oduncu F, Drexler E et al. The CD19+ B-cell counts at peripheral blood stem cell mobilization determine different levels of tumour contamination and autograft purgability in low-grade lymphoma. Br J Haematol 2002; 116: 695\u2013701.","journal-title":"Br J Haematol"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/1704551","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1704551.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1704551.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,23]],"date-time":"2022-03-23T23:48:14Z","timestamp":1648079294000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/1704551"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,5,31]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2004,7,1]]}},"alternative-id":["BF1704551"],"URL":"https:\/\/doi.org\/10.1038\/sj.bmt.1704551","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,5,31]]},"assertion":[{"value":"20 January 2004","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2004","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 May 2004","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}